Barr And Eli Lilly Head Back To Court Over Prozac

Five years after successfully challenging a patent for Eli Lilly's blockbuster antidepressant Prozac, Barr Laboratories and Eli Lilly will meet again in court, this time over a reissue patent for the...

Already a subscriber? Click here to view full article